Skip to main content

immunitoAI

immunitoAI

Type

Startup

Founded

2020

Funding captured

$6.1m

Deals captured

1

About immunitoAI

immunitoAI is a biotechnology-focused startup that applies computational methods and machine learning to immunology and antibody discovery. The company develops AI-driven platforms and workflows to design, optimise, and prioritise therapeutic antibodies and biologics, supporting preclinical research and translational development. Its core activities include in-silico candidate generation, predictive modelling of immune responses, and enabling partner research teams to accelerate biologics discovery and reduce experimental cycles.

immunitoAI funding captured (1)

Deal typeStageDateAmountInvestors
EquityUndisclosedNov 25, 2025$6.1m